Cell Surface Markers Market | Coherent Market Insights

1
Coherent Marketing Insights

• Market Research Business Consulting Services

• https//www.coherentmarketinsights.com/

• Covid-19 Impact Tracker

2

• CELL SURFACE MARKERS MARKET ANALYSIS
• Cell Surface Markers Market, By Product Type
  (Flow Cytometers, Hematology Analyzers, Reagents
  and Kits), By Application (Disease Diagnosis and
  identification, Research/Drug Discovery), and By
  Region (North America, Latin America, Europe,
  Asia Pacific, Middle East Africa) - Size,
  Share, Outlook, and Opportunity Analysis, 2020 -
  2027

3

• The global cell surface markers market is
  estimated to account for US 24,961.0 Mn in terms
  of value in 2020 and is expected to reach US
  44,373.4 Mn by the end of 2027.
• Global Cell Surface Markers Market Drivers
• Growing automation in laboratories is expected to
  propel growth of the global cell surface markers
  market over the forecast period. Huge inflow of
  data pertaining to patient details, clinical
  information, type of test, and the instruments
  required demands streamlining of such processes.
  Rapid detection of critical medical conditions
  can be easily facilitated through the use of
  sophisticated laboratory equipment such as flow
  cytometers. Availability of high-end and faster
  cell sorting and analysis solutions in flow
  cytometers for research and clinical development
  facilitates easier use of point of care diagnosis
  through automation of sample processing and
  enabling high throughput screening.

4

• Global Cell Surface Markers Market Share (), by
  Value, by Region, 2019

5

• Global Cell Surface Markers Market Restraints
• Reluctance in high investment in sophisticated
  models is expected to hinder growth of the
  market. Due to the complexity and high cost of
  instruments and the simultaneous uncertainty
  surrounding the regulation and reimbursement for
  cell marker diagnostic tests, many clinical
  laboratories are reluctant to invest in
  sophisticated cell marker analysis instruments.
  Need for such devices also depends on the size
  and nature of the diagnostic facility. Economic
  concerns regarding operational sustainability in
  medium and small sized clinical laboratories and
  hospitals results in the outsourcing of such
  tasks to larger clinical laboratories.
• Moreover, small pharmaceutical companies also are
  becoming increasingly reluctant to invest in
  highly sophisticated flow cytometers and
  hematology analyzers, owing to the unclear
  cost-benefit relationship. As drug development
  itself is a costly affair, smaller pharmaceutical
  firms cannot afford to get involved in the
  purchase of expensive equipment and consumables.
  This is turn is also expected to limit market
  growth.

6
Cell Surface Markers Market Report Coverage

7

• Global Cell Surface Markers Market Opportunities
  
• Cell surface markers play a vital role in drug
  discovery and personalized medicine. Thus
  investment in drug discovery and personalized
  medicine is expected to offer lucrative growth
  opportunities for players in the global cell
  surface markers market. For instance, in May
  2020, The Israel Precision Medicine Partnership
  has chosen 16 multidisciplinary projects that
  will together receive around US 17 million in
  funding for developing nanoparticles to treat
  cancer, identifying genes to fight inherited
  retinal diseases, and studying the genetic
  aspects of autism.
• Moreover, RD in adoptive immunotherapies is also
  expected to aid in growth of the market. For
  instance, in March 2020, researchers from
  Institute for Tumor Biology and Experimental
  Therapy, Germany, reported examining expression
  of various NK-cell-associated cell surface
  markers in the different feeder cell-expanded NK
  cell pools in the research Directed
  Differentiation of Mobilized Hematopoietic Stem
  and Progenitor Cells into Functional NK Cells
  with Enhanced Antitumor Activity.
• The global cell surface markers market was valued
  at US 23,037.4 Mn in 2019 and is forecast to
  reach a value of US 44,373.4 Mn by 2027 at a
  CAGR of 8.6 between 2020 and 2027.

8
Global Cell Surface Markers Market Value (US
Mn), and Y-o-Y Growth (), 2019-2027

9

• Market Trends/Key Takeaways
• Cell surface marker analysis through the use of
  technologies like flow cytometry is expected to
  allow simplification of disease analysis, sample
  preparation and disease diagnosis. Currently a
  wide range of assay technologies for cell surface
  marker research are available in the market to
  enable the analysis of gene expression and
  regulation, genotyping, signal transduction and
  epigenetic modification. Some of the most common
  solutions available for cell surface marker
  analysis are PCR array, siRNA, miRNA, pathway
  reporter, mutation analysis, DNA methylation,
  protein expression and chromatin IP products.
• Complexity of high-end flow cytometers and high
  cost of reagents, controls and analysis systems
  result in lowering the adoption of sophisticated
  cell marker analysis solutions, particularly in
  emerging economies. Increased market
  consolidation, simplification of analysis
  products, cost containment of such products and
  introduction of cheaper products is required to
  sustain in the cell surface markers market in
  such regions.

10

• Global Cell Surface Markers Market Competitive
  Landscape
• Major players operating in the global cell
  surface markers market include, Abbott
  Laboratories, Inc., Beckman Coulter, Inc., BD
  Biosciences, Bio-Rad Laboratories, Inc., Grifols
  SA, Immucor, Inc., Janssen Diagnostics, Inc.,
  Nihon Kohden Corporation, F. Hoffmann-La Roche
  Ltd., Siemens Healthcare, Sysmex Corporation, and
  Thermo Fisher Scientific, Inc.
• Global Cell Surface Markers Market Key
  Developments
• Major players in the market are focused on
  product approval and launch to expand their
  product portfolio. For instance, in May 2020,
  Beckman Coulter launched its DxH 690T hematology
  analyzer featuring mid-volume laboratories
  advanced features such as the Early Sepsis
  Indicator in the U.S.

11

• Request Sample Report
• Request Customization
• Download PDF Brochure
• Talk to Analyst
• Referance https//www.coherentmarketinsights.com/
  market-insight/cell-surface-markers-market-3912

12
About Us

• Coherent Market Insights is a global market
  intelligence and consulting organization focused
  on assisting our plethora of clients achieve
  transformational growth by helping them make
  critical business decisions. We are headquartered
  in India, having office at global financial
  capital in the U.S. Our client base includes
  players from across all business verticals in
  over 150 countries worldwide.
• What We ProvideCustomized Market Research
  AnalysisIndustry Analysis ServicesBusiness
  Consulting ServicesLong Term Engagement
  ModelCountry Specific Analysis

13
Contact Us

• Mr. Shah
• Coherent Market Insights Pvt. LTD.Coherent
  Market Insights 1001 4th Ave, 3200 Seattle, WA
  98154, U.S.Phone [phone]
• Email sales_at_coherentmarketinsights.com

14
Thank You

• Kindly Follow CMI Social Media Profiles for the
  latest Company Updates.
• Facebook
• Linkedin
• Twitter
• https//www.coherentmarketinsights.com/